Antiparasitic Drugs Market by Drug Type (Anthelmintics, Antiprotozoals, Ectoparasiticides), Form (Injections, Oral Tablets/Capsules, Topical Creams), Indication, Distribution Channel, End-User - Global Forecast 2024-2030
Antiparasitic Drugs Market by Drug Type (Anthelmintics, Antiprotozoals, Ectoparasiticides), Form (Injections, Oral Tablets/Capsules, Topical Creams), Indication, Distribution Channel, End-User - Global Forecast 2024-2030
The Antiparasitic Drugs Market size was estimated at USD 20.40 billion in 2023 and expected to reach USD 21.12 billion in 2024, at a CAGR 4.59% to reach USD 27.94 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Antiparasitic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antiparasitic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Antiparasitic Drugs Market, highlighting leading vendors and their innovative profiles. These include Adva Care Pharma, Algen Healthcare Ltd., Amneal Pharmaceuticals LLC, Bayer AG, Ben Pharmaceuticals, Centurion Laboratories Private Limited, Cipla Ltd., Consern Pharma Limited, Dr.Reddys Laboratories Inc., F. Hoffmann-La Roche AG, Fredun Group, Garcia Life Sciences, Glaxosmithkline PLC, Healthy Life Pharma Private Limited, Ipca Laboratories, Jackson Laboratories Pvt Ltd., Mankind Pharma, Merck KgaA, Novartis AG, Sanofi, Soigner Pharma by Arlak Biotech, Sriwalls Health Care, Taj Life Sciences Pvt. Ltd., Weefsel Pharma, and Zydus Group.
Market Segmentation & Coverage
This research report categorizes the Antiparasitic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
Drug Type
Anthelmintics
Antiprotozoals
Ectoparasiticides
Endoparaciticides
Form
Injections
Oral Tablets/Capsules
Topical Creams
Indication
Fleas
Intestinal Parasites
Lice
Malaria
Scabies
Ticks
Distribution Channel
Offline
Online
End-User
Home Care Facilities
Hospitals & Clinics
Veterinary Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom The report offers valuable insights on the following aspects:
Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
What is the market size and forecast of the Antiparasitic Drugs Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antiparasitic Drugs Market?
What are the technology trends and regulatory frameworks in the Antiparasitic Drugs Market?
What is the market share of the leading vendors in the Antiparasitic Drugs Market?
Which modes and strategic moves are suitable for entering the Antiparasitic Drugs Market?
Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Antiparasitic Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence and awareness of parasite infection across the globe
5.1.1.2. Favorable government initiatives for parasite infection management
5.1.1.3. Increasing investment in research and development activities
5.1.2. Restraints
5.1.2.1. Requirement of huge capital for drug development
5.1.3. Opportunities
5.1.3.1. Surge in approvals for antiparasitic drugs from several regulatory authorities
5.1.3.2. Introduction of novel antiparasitic drugs by manufacturers
5.1.4. Challenges
5.1.4.1. Adverse effects and risks associated with the drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Antiparasitic Drugs Market, by Drug Type
6.1. Introduction
6.2. Anthelmintics
6.3. Antiprotozoals
6.4. Ectoparasiticides
6.5. Endoparaciticides
7. Antiparasitic Drugs Market, by Form
7.1. Introduction
7.2. Injections
7.3. Oral Tablets/Capsules
7.4. Topical Creams
8. Antiparasitic Drugs Market, by Indication
8.1. Introduction
8.2. Fleas
8.3. Intestinal Parasites
8.4. Lice
8.5. Malaria
8.6. Scabies
8.7. Ticks
9. Antiparasitic Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Antiparasitic Drugs Market, by End-User
10.1. Introduction
10.2. Home Care Facilities
10.3. Hospitals & Clinics
10.4. Veterinary Clinics
11. Americas Antiparasitic Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Antiparasitic Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Antiparasitic Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Adva Care Pharma
15.1.2. Algen Healthcare Ltd.
15.1.3. Amneal Pharmaceuticals LLC
15.1.4. Bayer AG
15.1.5. Ben Pharmaceuticals
15.1.6. Centurion Laboratories Private Limited
15.1.7. Cipla Ltd.
15.1.8. Consern Pharma Limited
15.1.9. Dr.Reddys Laboratories Inc.
15.1.10. F. Hoffmann-La Roche AG
15.1.11. Fredun Group
15.1.12. Garcia Life Sciences
15.1.13. Glaxosmithkline PLC
15.1.14. Healthy Life Pharma Private Limited
15.1.15. Ipca Laboratories
15.1.16. Jackson Laboratories Pvt Ltd.
15.1.17. Mankind Pharma
15.1.18. Merck KgaA
15.1.19. Novartis AG
15.1.20. Sanofi
15.1.21. Soigner Pharma by Arlak Biotech
15.1.22. Sriwalls Health Care
15.1.23. Taj Life Sciences Pvt. Ltd.
15.1.24. Weefsel Pharma
15.1.25. Zydus Group
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. ANTIPARASITIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTIPARASITIC DRUGS MARKET SIZE, 2023 VS 2030